These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35618721)

  • 1. An integral genomic signature approach for tailored cancer therapy using genome-wide sequencing data.
    Wang XS; Lee S; Zhang H; Tang G; Wang Y
    Nat Commun; 2022 May; 13(1):2936. PubMed ID: 35618721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data.
    Lee S; Sun M; Hu Y; Wang Y; Islam MN; Goerlitz D; Lucas PC; Lee AV; Swain SM; Tang G; Wang XS
    BMC Bioinformatics; 2024 Jun; 25(1):220. PubMed ID: 38898383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data.
    Lee S; Sun M; Hu Y; Wang Y; Islam MN; Goerlitz D; Lucas PC; Lee AV; Swain SM; Tang G; Wang XS
    Res Sq; 2023 Nov; ():. PubMed ID: 38077030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative omics analyses broaden treatment targets in human cancer.
    Sengupta S; Sun SQ; Huang KL; Oh C; Bailey MH; Varghese R; Wyczalkowski MA; Ning J; Tripathi P; McMichael JF; Johnson KJ; Kandoth C; Welch J; Ma C; Wendl MC; Payne SH; Fenyö D; Townsend RR; Dipersio JF; Chen F; Ding L
    Genome Med; 2018 Jul; 10(1):60. PubMed ID: 30053901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Treatment in the Genomic Era.
    Doherty GJ; Petruzzelli M; Beddowes E; Ahmad SS; Caldas C; Gilbertson RJ
    Annu Rev Biochem; 2019 Jun; 88():247-280. PubMed ID: 30901264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.
    Ding MQ; Chen L; Cooper GF; Young JD; Lu X
    Mol Cancer Res; 2018 Feb; 16(2):269-278. PubMed ID: 29133589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of cancer drug sensitivity based on genomic feature distribution alignment and drug structure information].
    Lian L; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2024 Jul; 40(7):2235-2245. PubMed ID: 39044587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
    Kim D; Li R; Lucas A; Verma SS; Dudek SM; Ritchie MD
    J Am Med Inform Assoc; 2017 May; 24(3):577-587. PubMed ID: 28040685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms.
    Kusch N; Schuppert A
    PLoS One; 2020; 15(11):e0238961. PubMed ID: 33226984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
    Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
    BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
    Malik V; Kalakoti Y; Sundar D
    BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.